Vanguard Global Advisers’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
Vanguard Global Advisers's ASTH Position: Q3 2026 in Review
Vanguard Global Advisers increased its Astrana Health (ASTH) stake by 24% in Q3 2026, buying an estimated $155K and bringing the position to 20,465 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.
Vanguard Global Advisers first reported a position in ASTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $767K in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- Vanguard Global Advisers held 20,465 shares of Astrana Health worth $728K as of Q3 2026.
- Vanguard Global Advisers bought 3,941 Astrana Health shares in Q3 2026, an estimated $155K.
- Astrana Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1910 holding.
- Vanguard Global Advisers first reported a position in Astrana Health in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Astrana Health position peaked at $767K in Q2 2026.
- 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.